Approximately half of Indiana's physicians received all or some of their education at
the IU School of Medicine...
A conversation exploring aesthetics through neuroscience and psychology with Dr. Anjan Chatterjee (
IU School of Medicine) and Juliet King (director of Herron's art therapy program).
The canine slides were compared to human specimens collected from the Department of Pathology at
the IU School of Medicine.
Peter J. Embi, MD, MS, FACP, FACMI President & CEO, Regenstrief Institute Sam Regenstrief Professor of Medicine, Associate Dean for Informatics & Health Services Research,
IU School of Medicine Associate Director of Informatics, Indiana CTSI Vice-President for Learning Health Systems, IU Health
To thank postdocs and postdoc faculty mentors for their efforts, the Office of Postdoctoral Affairs invites
IU School of Medicine postdocs, their PIs, faculty, graduate students and administrators to the Postdoc & Faculty Mentor Appreciation Reception on Friday, September 22 in the MS Atrium, 3:00 p.m. — 4:30 p.m..
Organized by
the IU School of Medicine Postdoctoral Association, the 3rd Annual IUSM Postdoc Symposium will feature a keynote speaker, posters and oral presentations!
Authors are Babar Khan, M.D., M.S., of the Regenstrief Institute, IU Center for Aging Research and
IU School of Medicine; Sue Lasiter, Ph.D., R.N., of the IU School of Nursing; and Malaz Boustani, M.D., MPH, of the Regenstrief Institute, IU Center for Aging Research and
IU School of Medicine.
«The CCRC is an interdisciplinary model of care focusing on the unique needs of ICU survivors, a growing population that does not receive specialized care it deserves,» said study senior author Babar A. Khan, MD, of the Indiana University Center for Aging Research, Regenstrief Institute, Center for Health Innovation and Implementation Science and
IU School of Medicine.
«We studied the outcomes of the ACT model across the entire hospital except the ICUs,» said study co-author Siu Hui, Ph.D., a Regenstrief Institute biostatistician and professor emeritus of biostatistics at
the IU School of Medicine.
Authors of «Redesigning Inpatient Care: Testing the Effectiveness of an Accountable Care Team Model» in addition to Dr. Kara and Dr. Hui are Cynthia S. Johnson, M.A., of
the IU School of Medicine and Richard Fairbanks School of Public Health, and Amy Nicley, R.N., M.S.N., and Michael R. Niemeier, M.D., both formerly with IU Health.
The ACT model was developed at Indiana University Health Methodist Hospital with consultation from
the IU School of Medicine's Center for Health Innovation and Implementation Science.
Meanwhile
another IU School of Medicine researcher, Theodore Cummins, Ph.D., professor of pharmacology and toxicology, had previously determined that carbamazepine alone has the opposite effect on the same ion channel.
The study, published online May 1 in Nature Biotechnology, was led by Karl R. Koehler, PhD, assistant professor in the Department of Otolaryngology and Head and Neck Surgery at
IU School of Medicine, and Dr. Hashino in collaboration with Jeffrey Holt, PhD, professor of otology and laryngology at Harvard Medical School and Boston Children's Hospital.
«Mindfulness meditation practices enable cancer survivors to better manage cancer - related cognitive impairment, reported by approximately 35 percent of cancer survivors who have completed treatment,» said Dr. Johns, who is a Regenstrief Institute investigator and assistant professor of medicine in
the IU School of Medicine.
«Not enough emphasis has been placed on assessing delirium severity in the ICU because there is a lack of understanding of how significant outcomes of delirium are for patients,» said
IU School of Medicine, IU Center for Aging Research, and Regenstrief Institute faculty member Babar A. Khan, MD, who led the study.
Dr. Boustani is the founder of the IU Center for Innovation and Implementation Science, deputy director of the IU Center for Aging Research,
an IU School of Medicine professor and a Regenstrief Institute investigator.
Lead author X. Charlie Dong, Ph.D., associate professor of biochemistry and molecular biology at
the IU School of Medicine, and colleagues monitored blood glucose levels and liver insulin sensitivity in mice with the endogenous Sestrin 3 protein and mice genetically engineered to not produce the protein.
The app - based questionnaires were developed separately, said Dr. Niculescu, director of the Laboratory of Neurophenomics at the Institute of Psychiatric Research at
the IU School of Medicine.
After running the simulations at IU Bloomington, Bacallao confirmed the cyst growth predictions seen in the virtual cysts in experiments using real human cells cultivated from polycystic kidneys from patients at
the IU School of Medicine.
«This is the first study to show the actual cell behaviors caused by mutations in genes causally linked to polycystic kidney disease, an important new step in the path towards treatment,» said Dr. Robert L. Bacallao, associate professor of medicine at
the IU School of Medicine in Indianapolis.
Working in the laboratory of Heather A. Hundley, corresponding author on the paper and an assistant professor of biochemistry and molecular biology in
the IU School of Medicine's Medical Sciences Program at Bloomington, Washburn and undergraduate Medical Sciences program student Emily Wheeler collaborated with the team from UCSD to show that the region of ADR - 1 protein that binds to target mRNAs in C. elegans is also required for regulating editing.
Not exact matches
In addition to He and Dibaba, other contributors included Pengcheng Xun, a faculty member in
IU's Department
of Epidemiology and Biostatistics; Kuninobu Yokota
of The Jikei University
School of Medicine in Tokyo, Japan; and Emily White
of the University
of Washington in Seattle.
Joan Lappe, Ph.D., R.N.,
of the Creighton University
Schools of Nursing and
Medicine, Omaha, and colleagues randomly assigned 2,303 healthy postmenopausal women 55 years or older (average age, 65 years) to the treatment group (n = 1,156; 2,000
IU / d
of vitamin D3 and 1,500 mg / d
of calcium) or to the placebo group (n = 1,147).
Mario Castro, M.D., M.P.H.,
of the Washington University
School of Medicine, St. Louis, and colleagues randomly assigned adults with asthma and low vitamin D levels to vitamin D3 (100,000
IU once, then 4,000
IU / daily for 28 weeks; n = 201) or placebo (n = 207), which was added to treatment with the inhaled corticosteroid ciclesonide.